Table VII.
Recommendations for clinical information and pathology report for suspected cSCC
| Clinical information provided to pathologist |
| Strongly recommended |
| • Age |
| • Sex |
| • Anatomic location |
| • Recurrent lesion |
| Recommended |
| • Size of lesion |
| • Immunosuppression |
| • History (especially radiation, burn, organ transplant) |
| Elements to be included in final pathology report (excision specimens) |
| Strongly recommended |
| • Degree of differentiation* |
| • Presence of aggressive histologic subtype† |
| • Depth of invasion, mm |
| • Clark level of invasion |
| • Perineural invasion |
| • Lymphovascular invasion |
| • Invasion of fascia, muscle, or bone |
| • Number of high-risk features‡ |
| • Margin status |
| • TNM stage (AJCC) |
| Recommended |
| • Inflammation |
| • Infiltrative strands, single cells, small nests |
| • Diameter of largest involved nerve |
AJCC, American Joint Committee on Cancer; cSCC, cutaneous squamous cell carcinoma; TNM, tumor, node, metastasis.
Well differentiated, moderately differentiated, poorly differentiated, or undifferentiated.
Acantholytic, adenosquamous, or carcinosarcomatous subtypes.
High-risk features include thickness greater than 2 mm, Clark level IV or V, poorly differentiated/undifferentiated, site on mucosa lip or ear, perineural invasion, and lymphovascular invasion.